BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28987055)

  • 1. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders.
    Rittman T; Ghosh BC; McColgan P; Breen DP; Evans J; Williams-Gray CH; Barker RA; Rowe JB
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):544-51. PubMed ID: 23303961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
    J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
    Tommasini L; Bonaccorsi J; Del Prete E; Cintoli S; Pagni C; Mazzucchi S; Palermo G; Morganti R; Frosini D; Siciliano G; Tognoni G; Ceravolo R
    Clin Neuropsychol; 2023 Aug; 37(6):1207-1220. PubMed ID: 35997036
    [No Abstract]   [Full Text] [Related]  

  • 10. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotypic behaviours in frontotemporal dementia and progressive supranuclear palsy.
    Prioni S; Redaelli V; Soliveri P; Fetoni V; Barocco F; Caffarra P; Scaglioni A; Tramacere I; Girotti F
    Cortex; 2018 Dec; 109():272-278. PubMed ID: 30399478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
    Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ; Konkel A; Dąbrowska M; Sławek J
    Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
    J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.